comparemela.com

Latest Breaking News On - Devin geiman guggenheim - Page 1 : comparemela.com

TherapeuticsMD, Inc (TXMD) Q1 2021 Earnings Call Transcript

Operator Good morning, ladies and gentlemen. Thank you for joining us for TherapeuticsMD first-quarter 2020 financial results conference call. [Operator instructions] I would now like to turn the call over to TherapeuticsMD s vice president of investor relations, Nichol Ochsner. Nichol? Nichol Ochsner Vice President, Investor Relations Good morning, everyone. Thank you for joining today to discuss our first-quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing our first-quarter financial results. The press release is available on the company s website therapeuticsmd.com and the Investors and Media section. On today s call from TherapeuticsMD are Chief Executive Officer Robert Finizio, Chief Financial Officer James D Arecca, Chief Commercial Officer Dawn Halkuff, and Chief Strategy and Performance Officer Mitchell Krassan. I would like to remind everyone that certain statements made during this conference call may be forw

Devin geiman guggenheimRob finizioDouglas tsaoRobert finizioMitchell krassanLouise chenNichol ochsnerJames dareccaDana flandersJen kim cantor fitzgeraldCantor fitzgeraldTherapeuticsmd incChief executive officer robert finizioChief financial officer jamesd areccaChief commercial officer dawn halkuffChief strategy

TherapeuticsMD, Inc (TXMD) Q4 2020 Earnings Call Transcript

Operator Good morning, ladies and gentlemen. Thank you for joining us for TherapeuticsMD fourth-quarter 2020 financial results conference call. [Operator instructions] I would now like to turn the call over to TherapeuticsMD s Vice President of Investor Relations Nichol Ochsner. Nichol? Nichol Ochsner Vice President, Investor Relations Thank you. Good morning, everyone. Thank you for joining today to discuss our fourth-quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing our fourth-quarter financial results. The press release is available on the company s website, therapeuticsmd.com in the investors and media section. On today s call from TherapeuticsMD are Chief Executive Officer Robert Finizio, Chief Financial Officer James D Arecca, Chief Commercial Officer Dawn Halkuff, and Chief Strategy and Performance Officer Mitchell Krassan. I would like to remind everyone that certain statements made during this conference cal

Devin geiman guggenheimRob finizioDouglas tsaoWhitney cummingsRobert finizioMitch krassanMitchell krassanLouise chenAnnabel samimyNichol ochsnerJames dareccaDana flandersLouise chen cantor fitzgeraldPop councilAnnabel samimy stifel financial corpTherapeuticsmd inc

Opko Health (OPK) Q4 2020 Earnings Call Transcript

Opko Health (OPK) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Opko Health (NASDAQ: OPK) Ladies and gentlemen, thank you for standing by, and welcome to the Opko Health fourth-quarter 2020 financial results conference call. [Operator instructions] I would now like to hand the conference to speaker today, Yvonne Briggs, LHA investor relations. Please go ahead ma am. Yvonne Briggs LHA Investor Relations Thank you, operator and good afternoon. This is Yvonne Briggs with LHA. Thank you all for joining today s call to discuss Opko Health financial results for the fourth quarter of 2020. I d like to remind you that any statements made during this call by management other than statements of historical fact will be considered forward-looking and as such, will be subject to risks and uncertainties that could materially affect the company s expected results.

United statesNew yorkUnited kingdomYale jen laidlawEdward tenthoff piper sandlerMike petuskySteve rubinPhillip frostYi chenDevin geimanDevin geiman guggenheimVifor freseniusYale jenSteven rubinJon cohenEdward tenthoff

vimarsana © 2020. All Rights Reserved.